{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:21:55Z","timestamp":1791130915123,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-026-00603-1","type":"journal-article","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T23:14:25Z","timestamp":1783293265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dyslipidemia in Saudi Arabia: A Systematic Review and Meta-Analysis of Population-Based Studies (2000\u20132025)"],"prefix":"10.1007","volume":"16","author":[{"given":"Abdulaziz Fahd","family":"Alkaabba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir Ibrahim","family":"Alsenaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Abdullah","family":"Bin Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa Ahmed","family":"AlQahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansuor A","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Hammad","family":"Altemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"603_CR1","volume-title":"Global status report on noncommunicable diseases 2022","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Global status report on noncommunicable diseases 2022. Geneva: WHO; 2022."},{"issue":"8","key":"603_CR2","first-page":"713","volume":"82","author":"GA Roth","year":"2023","unstructured":"Roth GA, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132021. J Am Coll Cardiol. 2023;82(8):713\u201339.","journal-title":"J Am Coll Cardiol"},{"issue":"10304","key":"603_CR3","first-page":"1223","volume":"398","author":"P Joseph","year":"2021","unstructured":"Joseph P, et al. Modifiable risk factors, cardiovascular disease, and mortality in global populations. Lancet. 2021;398(10304):1223\u201337.","journal-title":"Lancet"},{"issue":"5","key":"603_CR4","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/S2214-109X(22)00116-4","volume":"10","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2022","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Global trends in total and LDL cholesterol from 1990 to 2021. Lancet Glob Health. 2022;10(5):e623\u201335.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"603_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, et al. 2019 ESC\/EAS guidelines for the management of dyslipidemias. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"12","key":"603_CR6","first-page":"e1669","volume":"9","author":"HF Rahim","year":"2021","unstructured":"Rahim HF, et al. Noncommunicable diseases in the Arab world: burden and policy responses. Lancet Glob Health. 2021;9(12):e1669\u201381.","journal-title":"Lancet Glob Health"},{"key":"603_CR7","first-page":"873229","volume":"9","author":"KF AlHabib","year":"2022","unstructured":"AlHabib KF, et al. Cardiovascular disease burden in the Middle East and North Africa: priorities for the next decade. Front Cardiovasc Med. 2022;9:873229.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"603_CR8","first-page":"115","volume":"17","author":"M AlShamiri","year":"2023","unstructured":"AlShamiri M, et al. Prevalence and predictors of dyslipidemia in GCC countries: a regional review. J Clin Lipidol. 2023;17(1):115\u201324.","journal-title":"J Clin Lipidol"},{"key":"603_CR9","volume-title":"Health Statistics Yearbook 2023","author":"Saudi Ministry of Health","year":"2024","unstructured":"Saudi Ministry of Health. Health Statistics Yearbook 2023. Riyadh: Ministry of Health; 2024."},{"issue":"9","key":"603_CR10","first-page":"995","volume":"42","author":"S Bahijri","year":"2021","unstructured":"Bahijri S, et al. Lifestyle and metabolic risk transitions in Saudi Arabia: implications for cardiovascular prevention. Saudi Med J. 2021;42(9):995\u20131005.","journal-title":"Saudi Med J"},{"key":"603_CR11","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1186\/s12889-022-14239-w","volume":"22","author":"AA Alkhaldy","year":"2022","unstructured":"Alkhaldy AA, et al. National prevalence of obesity and diabetes among adults in Saudi Arabia: results from a population-based study. BMC Public Health. 2022;22:1854.","journal-title":"BMC Public Health"},{"key":"603_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12902-021-00788-5","volume":"21","author":"AA Ahmed","year":"2021","unstructured":"Ahmed AA, et al. Population-based estimates of dyslipidemia prevalence in Saudi adults: a narrative synthesis. BMC Endocr Disord. 2021;21:242.","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"603_CR13","first-page":"3945","volume":"12","author":"T AlAmri","year":"2020","unstructured":"AlAmri T, et al. Prediabetes and lipid abnormalities among primary-care patients in Jeddah, Saudi Arabia. Nutrients. 2020;12(12):3945.","journal-title":"Nutrients"},{"issue":"24","key":"603_CR14","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, et al. 2018 AHA\/ACC guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285\u2013350.","journal-title":"J Am Coll Cardiol"},{"key":"603_CR15","unstructured":"Saudi Vision. 2030. Health Sector Transformation Program 2022\u20132030. Riyadh: Saudi Council of Economic and Development Affairs; 2022."},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"24","key":"603_CR17","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA\/ACC guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285\u2013350.","journal-title":"J Am Coll Cardiol"},{"key":"603_CR18","unstructured":"Moola S, Munn Z, Tufanaru C, et al. Joanna Briggs Institute (JBI) critical appraisal checklist for prevalence studies. JBI Manual for Evidence Synthesis; 2020."},{"key":"603_CR19","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"issue":"3","key":"603_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"1","key":"603_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5414\/CP203549","volume":"58","author":"S Enani","year":"2020","unstructured":"Enani S, Bahijri SM, Malibary M, et al. Awareness, treatment, and control of dyslipidemia in primary health care settings in Jeddah, Saudi Arabia. Int J Clin Pharmacol Ther. 2020;58(1):37\u201344.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"7109","key":"603_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. Included Studies.","journal-title":"BMJ"},{"issue":"12","key":"603_CR23","first-page":"1955","volume":"26","author":"MM Al-Nozha","year":"2005","unstructured":"Al-Nozha MM, Arafah MR, Al-Mazrou YY, et al. Hyperlipidemia in Saudi Arabia. Saudi Med J. 2005;26(12):1955\u201361.","journal-title":"Saudi Med J"},{"issue":"2","key":"603_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.15537\/1658-3175.4235","volume":"29","author":"MM Al-Nozha","year":"2008","unstructured":"Al-Nozha MM, Al-Mazrou YY, Al-Maatouq MA, et al. Dyslipidemia in Saudi Arabia. Saudi Med J. 2008;29(2):282\u20137.","journal-title":"Saudi Med J"},{"key":"603_CR25","first-page":"587","volume":"190","author":"M Basulaiman","year":"2014","unstructured":"Basulaiman M, El Bcheraoui C, Tuffaha M, et al. Hypercholesterolemia and associated risk factors\u2014Kingdom of Saudi Arabia, 2013. Int J Cardiol. 2014;190:587\u201394.","journal-title":"Int J Cardiol"},{"issue":"4","key":"603_CR26","first-page":"201","volume":"7","author":"L Al-Khudairy","year":"2019","unstructured":"Al-Khudairy L, et al. Dyslipidemia prevalence among Saudi adults in Riyadh. Saudi J Med Med Sci. 2019;7(4):201\u20138.","journal-title":"Saudi J Med Med Sci"},{"issue":"2","key":"603_CR27","first-page":"97","volume":"29","author":"AM Al-Qahtani","year":"2022","unstructured":"Al-Qahtani AM, et al. Prevalence of dyslipidemia in Najran region, Saudi Arabia. J Family Community Med. 2022;29(2):97\u2013103.","journal-title":"J Family Community Med"},{"issue":"1","key":"603_CR28","first-page":"44","volume":"12","author":"MY Ghazwani","year":"2023","unstructured":"Ghazwani MY, et al. Dyslipidemia awareness and treatment in Jazan region. J Family Med Prim Care. 2023;12(1):44\u201350.","journal-title":"J Family Med Prim Care"},{"issue":"9","key":"603_CR29","first-page":"911","volume":"38","author":"Y Al-Saleh","year":"2017","unstructured":"Al-Saleh Y, et al. Prevalence of lipid abnormalities among adults in Tabuk region. Saudi Med J. 2017;38(9):911\u20138.","journal-title":"Saudi Med J"},{"issue":"1","key":"603_CR30","first-page":"19","volume":"24","author":"SN Al-Shehri","year":"2017","unstructured":"Al-Shehri SN, Al-Shahrani SI, Al-Qahtani SM, et al. Dyslipidemia among adults in Abha city, Saudi Arabia. J Family Community Med. 2017;24(1):19\u201325.","journal-title":"J Family Community Med"},{"issue":"1","key":"603_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2991\/jegh.k.191207.001","volume":"10","author":"S Al-Musharaf","year":"2020","unstructured":"Al-Musharaf S, Al-Muwalid A, et al. Dyslipidemia and lifestyle risk factors among Saudi adults. J Epidemiol Glob Health. 2020;10(1):36\u201344.","journal-title":"J Epidemiol Glob Health"},{"issue":"12","key":"603_CR32","first-page":"e0168388","volume":"11","author":"MK Alshaikh","year":"2016","unstructured":"Alshaikh MK, Filippidis FT, Al-Omar HA, et al. Awareness and control of cardiovascular risk factors in Saudi women: a national survey. PLoS ONE. 2016;11(12):e0168388.","journal-title":"PLoS ONE"},{"issue":"1","key":"603_CR33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5144\/0256-4947.2006.43","volume":"26","author":"FA Al-Muhanna","year":"2006","unstructured":"Al-Muhanna FA, Al-Sabban EA, Al-Fayez SF. Serum cholesterol and triglyceride levels in Saudi adults in Eastern Province. Ann Saudi Med. 2006;26(1):43\u20138.","journal-title":"Ann Saudi Med"},{"issue":"3","key":"603_CR34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/1658-631X.188246","volume":"4","author":"S Al-Enazi","year":"2016","unstructured":"Al-Enazi S, Qureshi NA, Bashir S, et al. Dyslipidemia in adults attending primary care clinics in Madinah. Saudi J Med Med Sci. 2016;4(3):202\u20137.","journal-title":"Saudi J Med Med Sci"},{"key":"603_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/1471-2458-12-354","volume":"12","author":"HM Al-Hazzaa","year":"2012","unstructured":"Al-Hazzaa HM, Abahussain NA, Al-Sobayel HI, et al. Lifestyle factors and lipid abnormalities among Saudi adolescents. BMC Public Health. 2012;12:354.","journal-title":"BMC Public Health"},{"issue":"1","key":"603_CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/sjo.SJO_2_22","volume":"7","author":"EA Al-Faris","year":"2019","unstructured":"Al-Faris EA, Al-Khaldi Y, Al-Amri S, et al. Dyslipidemia among Saudi university students. Saudi J Obes. 2019;7(1):15\u201322.","journal-title":"Saudi J Obes"},{"issue":"1","key":"603_CR37","first-page":"34","volume":"40","author":"SH Al-Amri","year":"2019","unstructured":"Al-Amri SH, Al-Khaldi YM, et al. Dyslipidemia prevalence and predictors among adults in Asir region. Saudi Med J. 2019;40(1):34\u201340.","journal-title":"Saudi Med J"},{"issue":"3","key":"603_CR38","first-page":"288","volume":"3","author":"NM Al-Daghri","year":"2010","unstructured":"Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Dyslipidemia and metabolic syndrome in Saudi Arabia. Int J Clin Exp Med. 2010;3(3):288\u201394.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"603_CR39","first-page":"173","volume":"7","author":"AJ Al-Zahrani","year":"2019","unstructured":"Al-Zahrani AJ, Al-Khudairy YM, Al-Daghri NM, et al. Prevalence of dyslipidemia among primary health care attendees in Makkah. Saudi J Med Med Sci. 2019;7(3):173\u20139.","journal-title":"Saudi J Med Med Sci"},{"issue":"2","key":"603_CR40","first-page":"102","volume":"6","author":"KE Medani","year":"2018","unstructured":"Medani KE, Al Mansour MA, Mohamed EY, et al. Prevalence of dyslipidemia among adults in Majmaah, Saudi Arabia. Majmaah J Health Sci. 2018;6(2):102\u20139.","journal-title":"Majmaah J Health Sci"},{"issue":"5","key":"603_CR41","first-page":"326","volume":"27","author":"A Al-Othaimeen","year":"2007","unstructured":"Al-Othaimeen A, Al-Nozha M, Osman AK. Serum lipid profile among Saudis: a community-based study. Ann Saudi Med. 2007;27(5):326\u201331.","journal-title":"Ann Saudi Med"},{"issue":"2","key":"603_CR42","first-page":"157","volume":"10","author":"SM Al-Shahrani","year":"2021","unstructured":"Al-Shahrani SM, et al. Dyslipidemia prevalence in Abha PHC attendees. Int J Med Sci Public Health. 2021;10(2):157\u201363.","journal-title":"Int J Med Sci Public Health"},{"issue":"4","key":"603_CR43","first-page":"1","volume":"11","author":"AM El-Daloa","year":"2017","unstructured":"El-Daloa AM, Hamama HH. Prevalence of dyslipidemia among university students in Taif. Int J Health Sci. 2017;11(4):1\u20138.","journal-title":"Int J Health Sci"},{"issue":"3","key":"603_CR44","first-page":"409","volume":"24","author":"HM Al-Hazzaa","year":"2014","unstructured":"Al-Hazzaa HM, Musaiger AO, Abahussain NA, et al. Physical activity, sedentary behaviors and dyslipidemia in Saudi adolescents. Nutr Metab Cardiovasc Dis. 2014;24(3):409\u201316.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"603_CR45","first-page":"89","volume":"7","author":"YM Al-Khudairy","year":"2019","unstructured":"Al-Khudairy YM, et al. Dyslipidemia and associated factors in Riyadh adults. Saudi J Med Med Sci. 2019;7(2):89\u201395.","journal-title":"Saudi J Med Med Sci"},{"issue":"12","key":"603_CR46","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1185\/030079905X74871","volume":"21","author":"H Scharnagl","year":"2005","unstructured":"Scharnagl H, et al. High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients (DYSIS-Europe). Curr Med Res Opin. 2005;21(12):1927\u201334.","journal-title":"Curr Med Res Opin"},{"key":"603_CR47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2016.05.003","volume":"217","author":"J Rodr\u00edguez \u00c1lvarez","year":"2016","unstructured":"Rodr\u00edguez \u00c1lvarez J, et al. Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain (DYSIS-Spain Study). Int J Cardiol. 2016;217:183\u20139.","journal-title":"Int J Cardiol"},{"key":"603_CR48","first-page":"89","volume":"349","author":"D M\u00fcller-Wieland","year":"2022","unstructured":"M\u00fcller-Wieland D, et al. Prevalence, incidence, and treatment of dyslipidemia in patients with high or very high cardiovascular risk in Germany. Atherosclerosis. 2022;349:89\u201398.","journal-title":"Atherosclerosis"},{"key":"603_CR49","unstructured":"Bucholz EM et al. Prevalence and pred."},{"issue":"5","key":"603_CR50","first-page":"1162","volume":"12","author":"ictors of cholesterol","year":"2018","unstructured":"ictors of cholesterol. screening, awareness, and statin treatment among US adults. J Clin Lipidol. 2018;12(5):1162\u201372.","journal-title":"J Clin Lipidol"},{"issue":"4","key":"603_CR51","first-page":"1","volume":"174","author":"ML Daviglus","year":"2014","unstructured":"Daviglus ML, et al. Ethnic and sex differences in prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA Study. JAMA Intern Med. 2014;174(4):1\u20138.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"603_CR52","first-page":"223","volume":"20","author":"AO Musaiger","year":"2011","unstructured":"Musaiger AO, et al. Obesity, dietary patterns, and physical inactivity in the Arab Gulf states. Nutr Health. 2011;20(3):223\u201332.","journal-title":"Nutr Health"},{"issue":"3","key":"603_CR53","first-page":"318","volume":"13","author":"AA Saeed","year":"2019","unstructured":"Saeed AA, et al. Dyslipidemia in the Middle East: a systematic review. J Clin Lipidol. 2019;13(3):318\u201329.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"603_CR54","first-page":"81","volume":"41","author":"WY Al-Saeed","year":"2021","unstructured":"Al-Saeed WY, et al. Lipid profile abnormalities among adults in Riyadh. Ann Saudi Med. 2021;41(2):81\u20139.","journal-title":"Ann Saudi Med"},{"issue":"10","key":"603_CR55","first-page":"1212","volume":"36","author":"MA Al-Saif","year":"2015","unstructured":"Al-Saif MA, Al-Mohanna FA, Al-Jasser AO, et al. Dyslipidemia in Qassim region: a cross-sectional study in PHC centers. Saudi Med J. 2015;36(10):1212\u20138.","journal-title":"Saudi Med J"},{"issue":"2","key":"603_CR56","first-page":"223","volume":"19","author":"NA Al-Qahtani","year":"2022","unstructured":"Al-Qahtani NA, et al. Dyslipidemia among adults in Najran PHCs. Int J Med Sci. 2022;19(2):223\u201330.","journal-title":"Int J Med Sci"},{"issue":"7","key":"603_CR57","first-page":"707","volume":"41","author":"MH Al-Sheikh","year":"2020","unstructured":"Al-Sheikh MH, et al. Dyslipidemia in Eastern Province PHCs. Saudi Med J. 2020;41(7):707\u201314.","journal-title":"Saudi Med J"},{"key":"603_CR58","first-page":"241","volume":"13","author":"AM Al-Hazmi","year":"2020","unstructured":"Al-Hazmi AM, et al. Dyslipidemia and associated factors among adults attending PHCs in Makkah. Int J Gen Med. 2020;13:241\u20139.","journal-title":"Int J Gen Med"},{"issue":"2","key":"603_CR59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/sjhs.sjhs_180_19","volume":"9","author":"SA Al-Farsi","year":"2020","unstructured":"Al-Farsi SA, et al. Dyslipidemia among Tabuk university staff. Saudi J Health Sci. 2020;9(2):102\u20138.","journal-title":"Saudi J Health Sci"},{"issue":"3","key":"603_CR60","first-page":"178","volume":"28","author":"AS Al-Shahrani","year":"2021","unstructured":"Al-Shahrani AS, et al. Lipid abnormalities among PHC patients in Abha. J Family Community Med. 2021;28(3):178\u201385.","journal-title":"J Family Community Med"},{"issue":"1","key":"603_CR61","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1476-511X-10-123","volume":"20","author":"Y Lu","year":"2021","unstructured":"Lu Y, et al. Prevalence of dyslipidemia and lipid goal attainment among adults in China: a nationwide cross-sectional study. Lipids Health Dis. 2021;20(1):123.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"603_CR62","first-page":"89401","volume":"11","author":"C Li","year":"2021","unstructured":"Li C, et al. Dyslipidemia among adults in China: prevalence and associated factors from a population-based study. Sci Rep. 2021;11(1):89401.","journal-title":"Sci Rep"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-026-00603-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00603-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00603-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:02:14Z","timestamp":1787608934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-026-00603-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s44197-026-00603-1","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This systematic review used only published data; no human or animal subjects were involved. Ethical approval and consent were not required. The review followed the Declaration of Helsinki and PRISMA 2020 guidelines.","order":1,"name":"Ethics","label":"Ethical Considerations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"106"}}